• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药品定价与报销。社区药剂师的新文化。

Pricing and reimbursement of pharmaceuticals. A new culture for the community pharmacist.

作者信息

Moen E, Toverud E L, Grund J, Brinchmann S

机构信息

Department of Social Pharmacy, School of Pharmacy, University of Oslo, Norway.

出版信息

Pharm World Sci. 1998 Jun;20(3):107-12. doi: 10.1023/a:1008651106315.

DOI:10.1023/a:1008651106315
PMID:9618733
Abstract

Pricing and reimbursement of pharmaceuticals are of concern for pharmacists. Different countries have different ways of organising their health care systems. The place for pharmaceuticals within these systems also differ. This article looks into the price- and reimbursement systems for medicinal products in Germany, Sweden, the UK and Norway. Various ways of organising the pharmaceutical market emerge. Some existing measures have been in place for a long time while others have been introduced more recently. A common goal for the four countries seems to be the drive to cut costs, and attempts to do this can be directed through various reimbursement systems, by focusing on prices or by influencing the physicians' prescribing behaviour, either through the use of advice or through the use of budgets. It is important for the pharmacists to have in-depth knowledge of the price- and reimbursement system they have to work within in order to be of full service to their customers.

摘要

药品定价和报销是药剂师所关心的问题。不同国家组织其医疗保健系统的方式各不相同。药品在这些系统中的地位也有所不同。本文探讨了德国、瑞典、英国和挪威的药品价格和报销制度。出现了各种组织药品市场的方式。一些现有措施已经实施了很长时间,而其他一些则是最近才引入的。这四个国家的一个共同目标似乎是削减成本的动力,实现这一目标的尝试可以通过各种报销系统来引导,通过关注价格或通过使用建议或预算来影响医生的处方行为。药剂师深入了解他们必须在其中工作的价格和报销系统,以便为客户提供全面服务,这一点很重要。

相似文献

1
Pricing and reimbursement of pharmaceuticals. A new culture for the community pharmacist.药品定价与报销。社区药剂师的新文化。
Pharm World Sci. 1998 Jun;20(3):107-12. doi: 10.1023/a:1008651106315.
2
Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.捷克共和国和瑞典的药品定价与报销
Pharm World Sci. 2008 Jan;30(1):57-64. doi: 10.1007/s11096-007-9141-z. Epub 2007 Jun 23.
3
[Pharmaceutical reference pricing in Germany: definition of therapeutic groups, price setting through regression procedure and effects].[德国的药品参考定价:治疗组的定义、通过回归程序设定价格及效果]
Gesundheitswesen. 2005 Jul;67(7):468-77. doi: 10.1055/s-2005-858485.
4
Impact of cross-reference pricing on pharmaceutical prices: manufacturers' pricing strategies and price regulation.交叉参考定价对药品价格的影响:制造商的定价策略与价格监管
Appl Health Econ Health Policy. 2006;5(4):235-47. doi: 10.2165/00148365-200605040-00005.
5
Provider-administered drugs move to specialty pharmacy benefit.由医疗机构提供的药物转至专科药房福利范畴。
Manag Care. 2014 Apr;23(4):49.
6
European prices of newly launched reimbursable pharmaceuticals--a pilot study.新上市可报销药品的欧洲价格——一项试点研究。
Health Policy. 2005 Nov;74(3):235-46. doi: 10.1016/j.healthpol.2005.01.005.
7
Reference pricing of pharmaceuticals for Medicare: evidence from Germany, The Netherlands, and New Zealand.医疗保险药品参考定价:来自德国、荷兰和新西兰的证据。
Front Health Policy Res. 2004;7:1-54. doi: 10.2202/1558-9544.1050.
8
The 1996 pricing and reimbursement policy in The Netherlands.1996年荷兰的定价与报销政策。
Pharmacoeconomics. 1996;10 Suppl 2:75-80. doi: 10.2165/00019053-199600102-00012.
9
Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.专科药房和其他受限药物分销系统:患者和医疗机构药师的财务和安全考虑。
Am J Health Syst Pharm. 2009 Dec 15;66(24 Suppl 7):S13-20. doi: 10.2146/ajhp090462.
10
Pricing and reimbursement of pharmaceuticals in Sweden.瑞典药品的定价与报销
Pharmacoeconomics. 1994;6 Suppl 1:51-60. doi: 10.2165/00019053-199400061-00013.

引用本文的文献

1
Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?德黑兰(伊朗)私人药店的财务视角;这是一个有利可图的生意吗?
Daru. 2012 Oct 22;20(1):62. doi: 10.1186/2008-2231-20-62.
2
Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.捷克共和国和瑞典的药品定价与报销
Pharm World Sci. 2008 Jan;30(1):57-64. doi: 10.1007/s11096-007-9141-z. Epub 2007 Jun 23.

本文引用的文献

1
Recent public policies in The Netherlands to control pharmaceutical pricing and reimbursement.荷兰近期控制药品定价和报销的公共政策。
Pharmacoeconomics. 1994;6 Suppl 1:15-21. doi: 10.2165/00019053-199400061-00007.
2
The role of pharmacoeconomics in health policy and management in Norway.药物经济学在挪威卫生政策与管理中的作用。
Pharmacoeconomics. 1995 Jun;7(6):475-83. doi: 10.2165/00019053-199507060-00002.
3
Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry.国际药品支出控制经验教训。三:规范行业。
BMJ. 1996 Jul 6;313(7048):33-5. doi: 10.1136/bmj.313.7048.33.
4
Lessons from international experience in controlling pharmaceutical expenditure. II: Influencing doctors.控制药品支出的国际经验教训。第二部分:影响医生。
BMJ. 1996 Jun 15;312(7045):1525-7. doi: 10.1136/bmj.312.7045.1525.
5
Effect of NHS reforms on general practitioners' referral patterns.英国国民医疗服务体系改革对全科医生转诊模式的影响。
BMJ. 1993 Feb 13;306(6875):433-7. doi: 10.1136/bmj.306.6875.433.
6
The German health care system at the crossroads.处于十字路口的德国医疗保健系统。
Health Econ. 1994 Sep-Oct;3(5):301-3. doi: 10.1002/hec.4730030503.